| Application no. and date | 15798609.2 (espacenet) (Federated) (European Patent Register), 20151106 | | Patent/reg. no. and date | DK/EP 3215122, 20250813 | | Publication date | 20170913 | | Priority no. and date | US 201462076770 P, 20141107, US 201462088061 P, 20141205 | | EP pub. no. and date |
EP 3215122 20170913 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | | | Inventor | ZHANG, Huixiang, c/o Alcon Research Ltd
6201 South Fwy
Fort Worth, Texas 76134, US,
BORING, Charles, c/o Alcon Research Ltd
4056 South Fwy
Fort Worth, Texas 76134, US,
KULSHRESHTHA, Alok, 3329 Lexington Avenue
Grapevine, Texas 76051, US,
ZENG, Yuhong, c/o Alcon Research
6201 South Fwy
Fort Worth, Texas 76134, US,
WAN, Li, c/o Alcon Research Ltd
6201 South Fwy
Fort Worth, Texas 76134, US,
ALANI, Laman, c/o Alcon Research Ltd
6201 South Fwy
Fort Worth, Texas 76134, US | | Representative | | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , A61K 9/00 (2006.01) , A61P 27/02 (2006.01) , A61P 43/00 (2006.01) , C07K 16/22 (2006.01) | | Title | STABLE PROTEIN SOLUTION FORMULATION CONTAINING HIGH CONCENTRATION OF AN ANTI-VEGF ANTIBODY | | Int. application no. | US2015059571 | | Int. publication no. | WO2016073915 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
